Back to Search
BRITTANY BUNDY, MD
MD
Pediatrics Physician
NPI: 1669113718Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
104403(GA)
Research & Publications (20)
High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection.
PMID 18841200·PLoS Negl Trop Dis·2008
8-other
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
PMID 18567002·Int J Cancer·2008
8-other
Escherichia coli-based cell-free synthesis of virus-like particles.
PMID 18023052·Biotechnol Bioeng·2008
8-other
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
PMID 17072745·Invest New Drugs·2007
8-other
Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
PMID 17493669·Gynecol Oncol·2007
3-trial
Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
PMID 18056178·Clin Cancer Res·2007
8-other
Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
PMID 16446331·J Clin Oncol·2006
2-rct
A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
PMID 16427212·Int J Radiat Oncol Biol Phys·2006
3-trial
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
PMID 16213007·Gynecol Oncol·2006
3-trial
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
PMID 16344461·Proc Natl Acad Sci U S A·2005
8-other
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
PMID 16230678·J Clin Oncol·2005
3-trial
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.
PMID 16039699·Gynecol Oncol·2005
3-trial
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
PMID 15936846·Lung Cancer·2005
8-other
Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
PMID 15913742·Gynecol Oncol·2005
3-trial
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
PMID 15911865·J Clin Oncol·2005
3-trial
Neuronal differentiation of NTE-deficient embryonic stem cells.
PMID 15823557·Biochem Biophys Res Commun·2005
7-preclinical
Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.
PMID 15618213·Infect Immun·2005
7-preclinical
Reassessment of pelvic lymph node debulking in advanced cervical cancer.
PMID 14984980·Gynecol Oncol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3003 W DR MARTIN LUTHER KING JR BLVD
TAMPA, FL 33607 - Phone
- (813) 554-8126
Quick Facts
- NPI
- 1669113718
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile